top of page

HT-29 Xenograft Model

Rincon Bio offers efficacy studies using the HT-29 Xenograft Model at our U.S.-based facilities, with direct access to the scientists conducting your study.

Model Type:
Xenograft
Organ:
Colon
ATCC link (if available):
Derivation:
Colorectal carcinoma of a 44yo female
Mutations:
APC, BRAF, PIK3CA, SMAD4, TP53
NCI60:
Yes
Weeks from stratification to termination (average):
N/A

HT-29 Growth Curve

(Representative of studies performed at Rincon Bio)

Representative tumor growth curve for the HT-29 xenograft model from studies performed at Rincon Bio.

For more information on this model, including available control data, please Contact Us, or request a Quote below

bottom of page